Biofilm Dynamics and Antimicrobial Resistance Mechanisms

Biofilms are structured communities of microorganisms that adhere to surfaces and become embedded within a self-produced matrix of extracellular polymeric substances (EPS). Their development proceeds through stages of initial, reversible attachment, irreversible adhesion, microcolony formation, maturation and eventual dispersal of individual cells. Spatial heterogeneity within the matrix creates nutrient and oxygen gradients that drive phenotypic diversity, including dormant ‘persister’ cells with high tolerance to antimicrobial agents. Resistance arises from multiple, interlinked mechanisms: the physical barrier posed by EPS that limits antibiotic penetration; reduced metabolic rates of cells deep in the biofilm; up-regulation of efflux pumps; horizontal transfer of resistance genes; and cell-to-cell communication via quorum sensing networks. Biofilm-associated infections on indwelling medical devices and chronic wounds present significant clinical challenges, while in industrial and environmental settings they underlie fouling, corrosion and product contamination. Global efforts now focus on understanding dynamic biofilm behaviour and disrupting its protective mechanisms with targeted anti-virulence strategies, novel antimicrobial compounds, and surface-modification technologies to prevent establishment or promote dispersal.

Research from Nature Portfolio

Studies have demonstrated that combining phytochemicals with conventional drugs can profoundly impair biofilm robustness. One investigation showed that a plant-derived polyphenol markedly reduced Pseudomonas aeruginosa biofilm biomass when used alongside azithromycin or gentamicin, inhibiting key quorum sensing-mediated traits such as motility and pigment production. Another work introduced a small-molecule inhibitor of the TraP quorum sensing receptor in Staphylococcus aureus, which altered cell-wall synthesis and extracellular DNA release, thereby sensitising established biofilms to a range of antibiotics both in vitro and in animal infection models. A third development identified a benzimidazole derivative able to block S. aureus attachment and suppress virulence gene expression without killing the bacteria outright, offering a promising anti-virulence approach that prevents biofilm formation while reducing selective pressure for resistance.

Biofilm Dynamics and Antimicrobial Resistance Mechanisms publication trend

The graph below shows the total number of articles in biofilm dynamics and antimicrobial resistance mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Biofilm: A community of microorganisms attached to a surface and embedded in a self-generated matrix of polymers.

Extracellular polymeric substances (EPS): A complex mixture of polysaccharides, proteins, nucleic acids and lipids that form the biofilm matrix.

Quorum sensing: Chemical communication among bacterial cells that regulates collective behaviours including biofilm formation and virulence.

Persister cells: Dormant variants within a biofilm that survive antimicrobial treatment due to low metabolic activity rather than genetic resistance.

Anti-virulence strategy: An approach targeting bacterial pathogenic mechanisms, such as attachment or signalling, without directly killing cells to minimise resistance development.

References

1. Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents. The Open Microbiology Journal (2017).
2. Biofilms and device-associated infections.. Emerging Infectious Diseases (2001).
3. Beyond Risk: Bacterial Biofilms and Their Regulating Approaches. Frontiers in Microbiology (2020).
4. Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments. Journal of Genetic Engineering and Biotechnology (2021).
5. Attenuation of Pseudomonas aeruginosa biofilm formation by Vitexin: A combinatorial study with azithromycin and gentamicin. Scientific Reports (2016).
6. The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release. Scientific Reports (2016).
7. Suppression of Staphylococcus aureus biofilm formation and virulence by a benzimidazole derivative, UM-C162. Scientific Reports (2018).
8. Novel Strategies for the Prevention and Treatment of Biofilm Related Infections. International Journal of Molecular Sciences (2013).